There is currently no registered product in Singapore authorised for this indication
Materials and methods Experimental model and subject details Cells (H1703 (ATCC, LUSC), TRIP13 KO in H1703 [13] and H1437 (ATCC, LUAD)) were selected based on expression of TRIP13 and germline cancer (GC) genes, culture compatibility, or cancer origin and characteristics as described in previous research [13], in which also the pathology type and mutational background of these cells are described
Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer
Ozempic is not FDA-approved for weight management, it is approved for T-2 diabetes management
A potential link to human T-cell leukemia virus, type I-associated leukemogenesis
Data suggest that semaglutide may lower the 10-year risk of developing type 2 diabetes by as much as 60% in people with overweight and weight-related complications or with obesity while on treatment